2- (a) A registration statement on Form S-3 (File No. 333-18225) with respect to the Shares, including a prospectus subject to completion, has been prepared by the Company in conformity with the requirements of the Securities Act of 1933, as amended...Underwriting Agreement • January 27th, 1997 • Cambridge Neuroscience Inc • Pharmaceutical preparations • California
